Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study.
暂无分享,去创建一个
N. Soni | G. Sotgiu | M. Restrepo | S. Dore | Alejandro Rodríguez | P. Faverio | S. Aliberti | L. Reyes
[1] T. E. Hinds. Diseases , 2021, Modeling Biological Systems.
[2] W. Self,et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. , 2015, The New England journal of medicine.
[3] W. Self,et al. Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia. , 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[4] J. Ramirez,et al. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia? , 2015, Current opinion in infectious diseases.
[5] C. Arias,et al. A new antibiotic and the evolution of resistance. , 2015, The New England journal of medicine.
[6] Duane T. Wegener,et al. A National Survey of Skin Infections, Care Behaviors and MRSA Knowledge in the United States , 2014, PloS one.
[7] Richard G. Wunderink,et al. Clinical practice. Community-acquired pneumonia. , 2014, The New England journal of medicine.
[8] S. Ewig,et al. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] B. Webb,et al. Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia , 2013, Antimicrobial Agents and Chemotherapy.
[10] F. Blasi,et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective , 2013, Thorax.
[11] A. Anzueto,et al. What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents). , 2013, Infectious disease clinics of North America.
[12] Melissa J. Krauss,et al. Mupirocin and Chlorhexidine Resistance in Staphylococcus aureus in Patients with Community-Onset Skin and Soft Tissue Infections , 2012, Antimicrobial Agents and Chemotherapy.
[13] Tanielle Lobo. Royal London Hospital , 2012 .
[14] T. Schaberg,et al. Guidelines for the management of adult lower respiratory tract infections ‐ Full version , 2011, Clinical Microbiology and Infection.
[15] A. Akram,et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] A. Anzueto,et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia , 2011, European Respiratory Journal.
[17] J. Ramirez,et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. , 2011, The Lancet. Infectious diseases.
[18] S. Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] J. Wu,et al. Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan. , 2010, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[20] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[21] 古谷 良輔,et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.
[22] J. S. Bradley,et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J. Bartlett,et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] G. Ridgway,et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). , 2005, The Journal of antimicrobial chemotherapy.
[25] J. Twersky,et al. MANAGEMENT OF PNEUMONIA IN THE NURSING HOME , 1999, Journal of the American Geriatrics Society.
[26] Sheldon P Stone,et al. Community-acquired pneumonia , 1998, The Lancet.
[27] D. Moir. Medicine , 1894, The Indian medical gazette.
[28] W. Schaffner,et al. Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] K. Kapila,et al. Comparison of cefoxitin disc diffusion test, oxacillin screen agar, and PCR for mecA gene for detection of MRSA. , 2009, Indian journal of medical microbiology.